title: Tyrosine phosphorylation events during coxsackievirus B3 replication.
abstract: In order to study cellular and viral determinants of pathogenicity, interactions between coxsackievirus B3 (CVB3) replication and cellular protein tyrosine phosphorylation were investigated. During CVB3 infection of HeLa cells, distinct proteins become phosphorylated on tyrosine residues, as detected by the use of antiphosphotyrosine Western blotting. Two proteins of 48 and 200 kDa showed enhanced tyrosine phosphorylation 4 to 5 h postinfection (p.i.), although virus-induced inhibition of cellular protein synthesis had already occurred 3 to 4 h p.i. Subcellular fractionation experiments revealed distinct localization of tyrosine-phosphorylated proteins of 48 and 200 kDa in the cytosol and membrane fractions of infected cells, respectively. In addition, in Vero cells infected with CVB3, echovirus (EV)11, or EV12, increased tyrosine phosphorylation of a 200-kDa protein was detected 6 h p.i. Herbimycin A, a specific inhibitor of Src-like protein tyrosine kinases, was shown to inhibit virus-induced tyrosine phosphorylations and to reduce the production of progeny virions. In contrast, in cells treated with the inhibitors staurosporine and calphostin C, the synthesis of progeny virions was not affected. Immunoprecipitation experiments suggested that the tyrosine-phosphorylated 200-kDa protein in CVB3-infected cells is of cellular origin. In summary, these investigations have begun to unravel the effect of CVB3 as well as EV11 and EV12 replication on cellular tyrosine phosphorylation and support the importance of tyrosine phosphorylation events for effective virus replication. Such cellular phosphorylation events triggered in the course of enterovirus infection may enhance virus replication.
authors.affiliation: Institute for Pathology, Department of Molecular Pathology, University of Tübingen, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Huber
authors.forename: H C
authors.initials: HC
authors.lastname: Selinka
authors.forename: R
authors.initials: R
authors.lastname: Kandolf
mesh_terms: D000818:Animals; D016227:Benzoquinones; D002522:Chlorocebus aethiops; D029822:Enterovirus B, Human / Q000254:growth & development / Q000378:metabolism* / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D047029:Lactams, Macrocyclic; D009281:Naphthalenes / Q000494:pharmacology; D010766:Phosphorylation; D011233:Precipitin Tests; D011809:Quinones / Q000494:pharmacology; D017828:Rifabutin / Q000031:analogs & derivatives; D019311:Staurosporine / Q000494:pharmacology; D013347:Subcellular Fractions; D014443:Tyrosine / Q000378:metabolism*; D014709:Vero Cells; D014771:Virion; D014779:Virus Replication; D019061:src-Family Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D016227:Benzoquinones; D004791:Enzyme Inhibitors; D047029:Lactams, Macrocyclic; D009281:Naphthalenes; D011809:Quinones; C061465:calphostin complex; D017828:Rifabutin; D014443:Tyrosine; C020754:herbimycin; D019061:src-Family Kinases; D019311:Staurosporine